Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Aug;65(8):3430–3437. doi: 10.1128/iai.65.8.3430-3437.1997

Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes.

Y Charoenvit 1, V Fallarme 1, W O Rogers 1, J B Sacci Jr 1, M Kaur 1, J C Aguiar 1, L F Yuan 1, G Corradin 1, E Andersen 1, B Wizel 1, R A Houghten 1, A Oloo 1, P De la Vega 1, S L Hoffman 1
PMCID: PMC175485  PMID: 9234808

Abstract

The Plasmodium yoelii sporozoite surface protein 2 (PySSP2) is the target of protective cellular immunity. Cytotoxic T cells specific for the Plasmodium falciparum analog PfSSP2, also known as thrombospondin-related anonymous protein (TRAP), are induced in human volunteers immunized with irradiated sporozoites. PfSSP2 is an important candidate antigen for a multicomponent malaria vaccine. We generated and characterized three monoclonal antibodies (MAbs) specific for PfSSP2/TRAP. The MAbs PfSSP2.1 (immunoglobulin G1 [IgG1]), PfSSP2.2 (IgG2a), and PfSSP2.3 (IgM) were species specific and identified three distinct B-cell epitopes containing sequences DRYI, CHPSDGKC, and TRPHGR, respectively. PfSSP2.1 partially inhibited P. falciparum liver-stage parasite development in human hepatocyte cultures (42 and 86% in two experiments at 100 microg/ml). Mice immunized with vaccinia virus expressing full-length PfSSP2 protein produced antibodies to (DRYIPYSP)3, and humans living in malaria-endemic areas (Indonesia and Kenya), who have lifelong exposure and partial clinical immunity to malaria, had antibodies to both (DRYIPYSP)3 and (CHPSDGKCN)2. Mice immunized with multiple antigen peptides MAP4 (DRYIPYSP)3P2P30 and MAP4 (CHPSDGKCN)3P2P30 in TiterMax developed antibodies to sporozoites that partially inhibited sporozoite invasion of human hepatoma cells (39 to 71% at a serum dilution of 1:50 in three different experiments). The modest inhibitory activities of the MAbs and the polyclonal antibodies to PfSSP2/TRAP epitopes do not suggest that a single-component vaccine designed to induce antibodies against PfSSP2/TRAP will be protective. Nonetheless, the MAbs directed against PfSSP2, and the peptides recognized by these MAbs, will be essential reagents in the development of PfSSP2/TRAP as a component of a multivalent P. falciparum human malaria vaccine.

Full Text

The Full Text of this article is available as a PDF (211.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aidoo M., Lalvani A., Allsopp C. E., Plebanski M., Meisner S. J., Krausa P., Browning M., Morris-Jones S., Gotch F., Fidock D. A. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet. 1995 Apr 22;345(8956):1003–1007. doi: 10.1016/s0140-6736(95)90754-8. [DOI] [PubMed] [Google Scholar]
  2. Ak M., Bower J. H., Hoffman S. L., Sedegah M., Lees A., Carter M., Beaudoin R. L., Charoenvit Y. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites. Infect Immun. 1993 Jun;61(6):2493–2497. doi: 10.1128/iai.61.6.2493-2497.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cerami C., Kwakye-Berko F., Nussenzweig V. Binding of malarial circumsporozoite protein to sulfatides [Gal(3-SO4)beta 1-Cer] and cholesterol-3-sulfate and its dependence on disulfide bond formation between cysteines in region II. Mol Biochem Parasitol. 1992 Aug;54(1):1–12. doi: 10.1016/0166-6851(92)90089-3. [DOI] [PubMed] [Google Scholar]
  4. Charoenvit Y., Collins W. E., Jones T. R., Millet P., Yuan L., Campbell G. H., Beaudoin R. L., Broderson J. R., Hoffman S. L. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science. 1991 Feb 8;251(4994):668–671. doi: 10.1126/science.1704150. [DOI] [PubMed] [Google Scholar]
  5. Charoenvit Y., Leef M. F., Yuan L. F., Sedegah M., Beaudoin R. L. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect Immun. 1987 Mar;55(3):604–608. doi: 10.1128/iai.55.3.604-608.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cowan G., Krishna S., Crisanti A., Robson K. Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites. Lancet. 1992 Jun 6;339(8806):1412–1413. doi: 10.1016/0140-6736(92)91229-2. [DOI] [PubMed] [Google Scholar]
  7. Dame J. B., Williams J. L., McCutchan T. F., Weber J. L., Wirtz R. A., Hockmeyer W. T., Maloy W. L., Haynes J. D., Schneider I., Roberts D. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science. 1984 Aug 10;225(4662):593–599. doi: 10.1126/science.6204383. [DOI] [PubMed] [Google Scholar]
  8. Ey P. L., Prowse S. J., Jenkin C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978 Jul;15(7):429–436. doi: 10.1016/0161-5890(78)90070-6. [DOI] [PubMed] [Google Scholar]
  9. Geysen H. M., Meloen R. H., Barteling S. J. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A. 1984 Jul;81(13):3998–4002. doi: 10.1073/pnas.81.13.3998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hedstrom R. C., Campbell J. R., Leef M. L., Charoenvit Y., Carter M., Sedegah M., Beaudoin R. L., Hoffman S. L. A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull World Health Organ. 1990;68 (Suppl):152–157. [PMC free article] [PubMed] [Google Scholar]
  11. Hollingdale M. R., Nardin E. H., Tharavanij S., Schwartz A. L., Nussenzweig R. S. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. J Immunol. 1984 Feb;132(2):909–913. [PubMed] [Google Scholar]
  12. Houghten R. A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5131–5135. doi: 10.1073/pnas.82.15.5131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Khusmith S., Charoenvit Y., Kumar S., Sedegah M., Beaudoin R. L., Hoffman S. L. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science. 1991 May 3;252(5006):715–718. doi: 10.1126/science.1827210. [DOI] [PubMed] [Google Scholar]
  14. Khusmith S., Sedegah M., Hoffman S. L. Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infect Immun. 1994 Jul;62(7):2979–2983. doi: 10.1128/iai.62.7.2979-2983.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lee J. O., Rieu P., Arnaout M. A., Liddington R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell. 1995 Feb 24;80(4):631–638. doi: 10.1016/0092-8674(95)90517-0. [DOI] [PubMed] [Google Scholar]
  16. Mazier D., Mellouk S., Beaudoin R. L., Texier B., Druilhe P., Hockmeyer W., Trosper J., Paul C., Charoenvit Y., Young J. Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science. 1986 Jan 10;231(4734):156–159. doi: 10.1126/science.3510455. [DOI] [PubMed] [Google Scholar]
  17. Mellouk S., Berbiguier N., Druilhe P., Sedegah M., Galey B., Yuan L., Leef M., Charoenvit Y., Paul C., Hoffman S. Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull World Health Organ. 1990;68 (Suppl):52–59. [PMC free article] [PubMed] [Google Scholar]
  18. Müller H. M., Reckmann I., Hollingdale M. R., Bujard H., Robson K. J., Crisanti A. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J. 1993 Jul;12(7):2881–2889. doi: 10.1002/j.1460-2075.1993.tb05950.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pacheco N. D., Strome C. P., Mitchell F., Bawden M. P., Beaudoin R. L. Rapid, large-scale isolation of Plasmodium berghei sporozoites from infected mosquitoes. J Parasitol. 1979 Jun;65(3):414–417. [PubMed] [Google Scholar]
  20. Pancake S. J., Holt G. D., Mellouk S., Hoffman S. L. Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates. J Cell Biol. 1992 Jun;117(6):1351–1357. doi: 10.1083/jcb.117.6.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reichlin M. Use of glutaraldehyde as a coupling agent for proteins and peptides. Methods Enzymol. 1980;70(A):159–165. doi: 10.1016/s0076-6879(80)70047-2. [DOI] [PubMed] [Google Scholar]
  22. Robson K. J., Frevert U., Reckmann I., Cowan G., Beier J., Scragg I. G., Takehara K., Bishop D. H., Pradel G., Sinden R. Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytes. EMBO J. 1995 Aug 15;14(16):3883–3894. doi: 10.1002/j.1460-2075.1995.tb00060.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Robson K. J., Hall J. R., Davies L. C., Crisanti A., Hill A. V., Wellems T. E. Polymorphism of the TRAP gene of Plasmodium falciparum. Proc Biol Sci. 1990 Dec 22;242(1305):205–216. doi: 10.1098/rspb.1990.0126. [DOI] [PubMed] [Google Scholar]
  24. Robson K. J., Hall J. R., Jennings M. W., Harris T. J., Marsh K., Newbold C. I., Tate V. E., Weatherall D. J. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature. 1988 Sep 1;335(6185):79–82. doi: 10.1038/335079a0. [DOI] [PubMed] [Google Scholar]
  25. Rogers W. O., Malik A., Mellouk S., Nakamura K., Rogers M. D., Szarfman A., Gordon D. M., Nussler A. K., Aikawa M., Hoffman S. L. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9176–9180. doi: 10.1073/pnas.89.19.9176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rogers W. O., Rogers M. D., Hedstrom R. C., Hoffman S. L. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol Biochem Parasitol. 1992 Jul;53(1-2):45–51. doi: 10.1016/0166-6851(92)90005-5. [DOI] [PubMed] [Google Scholar]
  27. Scarselli E., Tolle R., Koita O., Diallo M., Müller H. M., Früh K., Doumbo O., Crisanti A., Bujard H. Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum. Infect Immun. 1993 Aug;61(8):3490–3495. doi: 10.1128/iai.61.8.3490-3495.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sharma P., Bharadwaj A., Bhasin V. K., Sailaja V. N., Chauhan V. S. Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite invasion in vitro. Infect Immun. 1996 Jun;64(6):2172–2179. doi: 10.1128/iai.64.6.2172-2179.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sinnis P., Clavijo P., Fenyö D., Chait B. T., Cerami C., Nussenzweig V. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med. 1994 Jul 1;180(1):297–306. doi: 10.1084/jem.180.1.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Templeton T. J., Kaslow D. C. Cloning and cross-species comparison of the thrombospondin-related anonymous protein (TRAP) gene from Plasmodium knowlesi, Plasmodium vivax and Plasmodium gallinaceum. Mol Biochem Parasitol. 1997 Jan;84(1):13–24. doi: 10.1016/s0166-6851(96)02775-2. [DOI] [PubMed] [Google Scholar]
  31. Valmori D., Pessi A., Bianchi E., Corradin G. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J Immunol. 1992 Jul 15;149(2):717–721. [PubMed] [Google Scholar]
  32. Valmori D., Romero J. F., Men Y., Maryanski J. L., Romero P., Corradin G. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur J Immunol. 1994 Jun;24(6):1458–1462. doi: 10.1002/eji.1830240633. [DOI] [PubMed] [Google Scholar]
  33. Wang R., Charoenvit Y., Corradin G., De La Vega P., Franke E. D., Hoffman S. L. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes. J Immunol. 1996 Nov 1;157(9):4061–4067. [PubMed] [Google Scholar]
  34. Wang R., Charoenvit Y., Corradin G., Porrozzi R., Hunter R. L., Glenn G., Alving C. R., Church P., Hoffman S. L. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J Immunol. 1995 Mar 15;154(6):2784–2793. [PubMed] [Google Scholar]
  35. Wizel B., Houghten R. A., Parker K. C., Coligan J. E., Church P., Gordon D. M., Ballou W. R., Hoffman S. L. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. J Exp Med. 1995 Nov 1;182(5):1435–1445. doi: 10.1084/jem.182.5.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wizel B., Houghten R., Church P., Tine J. A., Lanar D. E., Gordon D. M., Ballou W. R., Sette A., Hoffman S. L. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J Immunol. 1995 Jul 15;155(2):766–775. [PubMed] [Google Scholar]
  37. Wizel B., Rogers W. O., Houghten R. A., Lanar D. E., Tine J. A., Hoffman S. L. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. Eur J Immunol. 1994 Jul;24(7):1487–1495. doi: 10.1002/eji.1830240705. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES